Latest AASLD News

PPAR Agonist Led to ‘Clinically Meaningful’ Improvement in PBC-Related Pruritus

BOSTON -- The investigational agent seladelpar improved markers of disease activity and

Derick Alison Derick Alison

Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial

BOSTON -- Treatment with an investigational thyroid hormone receptor-beta (THR-β) agonist significantly

Derick Alison Derick Alison

Emergency Liver Transplant Effective for Severe Acute-on-Chronic Liver Failure

BOSTON -- Prioritizing emergency liver transplantation for patients with severe acute-on-chronic liver

Derick Alison Derick Alison

Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis

BOSTON -- An investigational dual peroxisome proliferator-activated receptor (PPAR) agonist appeared effective

Derick Alison Derick Alison

AKI Response Tied to Improved Survival for Patients Waiting on Liver Transplant

BOSTON -- For patients with cirrhosis waitlisted for liver transplant who were

Derick Alison Derick Alison

MASLD Predicted to Increase by 23% by Middle of the Century

BOSTON -- A mathematical model predicts that the prevalence of metabolic dysfunction-associated

Derick Alison Derick Alison